Articles in section Research & Development
| << Opinion & Analysis | 413 articles | Royalties >> |
| Pages 1 2 3 4 5 .. 42 | Next >> |
-
Novartis Collaborates with Precision Bio in Gene Editing Pact
-
Amphista Enters Protein Degradation Collaborations with Bristol-Myers Squibb and Merck
-
Takeda Signs US$400 M+ Gene Therapy Pact with Evozyne
-
Bristol Myers Squibb Signs US$1.1 B Metastatic Cancer Pact with Volastra
-
Curve Therapeutics Collaborates with Merck & Co. on Next Generation Drug Discovery Platform
-
Intellia and ONK Collaborate on CRISPR-Edited Cancer Cell Therapies
-
Amgen Delves into Protein Degrader Therapies with Plexium Collaboration
-
Janssen Bets US$1.4 B on Mersana’s ADC Platform
-
Biogen Bets US$30 M on Genentech’s Lymphoma Bispecific Antibody
-
Eli Lilly Bolsters Metabolic Portfolio with Evotec and Abbisko Collaborations
RSS